| First Author | Chlon TM | Year | 2021 |
| Journal | Cell Stem Cell | Volume | 28 |
| Issue | 11 | Pages | 1966-1981.e6 |
| PubMed ID | 34473945 | Mgi Jnum | J:326963 |
| Mgi Id | MGI:6871813 | Doi | 10.1016/j.stem.2021.08.004 |
| Citation | Chlon TM, et al. (2021) Germline DDX41 mutations cause ineffective hematopoiesis and myelodysplasia. Cell Stem Cell 28(11):1966-1981.e6 |
| abstractText | DDX41 mutations are the most common germline alterations in adult myelodysplastic syndromes (MDSs). The majority of affected individuals harbor germline monoallelic frameshift DDX41 mutations and subsequently acquire somatic mutations in their other DDX41 allele, typically missense R525H. Hematopoietic progenitor cells (HPCs) with biallelic frameshift and R525H mutations undergo cell cycle arrest and apoptosis, causing bone marrow failure in mice. Mechanistically, DDX41 is essential for small nucleolar RNA (snoRNA) processing, ribosome assembly, and protein synthesis. Although monoallelic DDX41 mutations do not affect hematopoiesis in young mice, a subset of aged mice develops features of MDS. Biallelic mutations in DDX41 are observed at a low frequency in non-dominant hematopoietic stem cell clones in bone marrow (BM) from individuals with MDS. Mice chimeric for monoallelic DDX41 mutant BM cells and a minor population of biallelic mutant BM cells develop hematopoietic defects at a younger age, suggesting that biallelic DDX41 mutant cells are disease modifying in the context of monoallelic DDX41 mutant BM. |
